Brain-derived neurotrophic factor, neurofilament light and glial fibrillary acidic protein do not change in response to aerobic training in people with MS-related fatigue – a secondary analysis of a randomized controlled trial

Autor: Gravesteijn, Arianne S, Beckerman, Heleen, Willemse, Eline AJ, Hulst, Hanneke E, de Jong, Brigit A, Teunissen, Charlotte E, de Groot, Vincent

Publikováno v: In Multiple Sclerosis and Related Disorders February 2023 70

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis.

Autor: van Lierop, Zoë YGJ, Wieske, Luuk, Koel-Simmelink, Marleen JA, Chatterjee, Madhurima, Dekker, Iris, Leurs, Cyra E, Willemse, Eline AJ, Moraal, Bastiaan, Barkhof, Frederik, Eftimov, Filip, Uitdehaag, Bernhard MJ, Killestein, Joep, Teunissen, Charlotte E

Publikováno v: Multiple Sclerosis Journal; Jan2022, Vol. 28 Issue 1, p102-110, 9p

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis.

Autor: van Lierop ZY; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Wieske L; Department of Neurology and Neurophysiology, Amsterdam UMC, Academisch Medisch Centrum, Amsterdam Neuroscience, Amsterdam, The Netherlands., Koel-Simmelink MJ; Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Neurochemistry Laboratory and Biobank, Amsterdam Neuroscience, Amsterdam, The Netherlands., Chatterjee M; Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Neurochemistry Laboratory and Biobank, Amsterdam Neuroscience, Amsterdam, The Netherlands., Dekker I; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands/Department of Rehabilitation Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Leurs CE; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Willemse EA; Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Neurochemistry Laboratory and Biobank, Amsterdam Neuroscience, Amsterdam, The Netherlands., Moraal B; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Barkhof F; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands/Institutes of Neurology and Healthcare Engineering, University College London, London, UK., Eftimov F; Department of Neurology and Neurophysiology, Amsterdam UMC, Academisch Medisch Centrum, Amsterdam Neuroscience, Amsterdam, The Netherlands., Uitdehaag BM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Killestein J; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Teunissen CE; Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Neurochemistry Laboratory and Biobank, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2022 Jan; Vol. 28 (1), pp. 102-110. Date of Electronic Publication: 2021 Apr 23.